Skip to main content
AXTA
NYSE Industrial Applications And Services

Axalta Plans North American Building Products Divestiture to Clear AkzoNobel Merger

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Neutral
Importance info
7
Price
$33.75
Mkt Cap
$7.223B
52W Low
$24.937
52W High
$38.61
52W Position info
35% above low
Off High info
13% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

AXTA sits 35% above its 52-week low of $24.937.

Summary

Axalta plans to divest its North American Building Products business to satisfy merger regulators, with the AkzoNobel deal still targeted to close in Q1 2027. No sale price or business size was disclosed.


Key Events · M&A and Partnerships · AXTA

  • Building Products Divestiture Planned

    Axalta is planning to sell its North American Building Products business to address regulatory requirements for the AkzoNobel merger. Management said the decision is driven by merger clearance, not business performance.

  • Merger Timetable Held at Q1 2027

    The merger of equals with AkzoNobel remains on track to close in Q1 2027, subject to remaining regulatory approvals and customary closing conditions.

  • Terms and Proceeds Undisclosed

    The filing gives no sale price, revenue or EBITDA figures for the Building Products business, so the earnings and valuation impact of the divestiture cannot yet be sized.

  • Second Remedy in Two Weeks

    Follows AkzoNobel's 2026-10-05 agreement to sell its Decorative Paints business in seven Southeast Asian countries to Nippon, and the 2026-10-08 report that EU regulators are expected to clear the deal with conditions.


Analysis · AXTA · Industrial Applications And Services

Regulators are requiring Axalta to sell its North American Building Products business as a condition of the merger of equals with AkzoNobel, so the company is preparing that divestiture. This is a real change to the asset base shareholders will own post-close, not a performance problem — management says the business is strong and the sale is driven by antitrust requirements. With the merger still targeted for Q1 2027, the divestiture is the concrete step that keeps that timetable alive. Because neither the size of the business nor the proceeds are disclosed, the earnings and valuation impact cannot yet be quantified.

How filings like this one have moved

In the 30 days to Oct 20, 2026, 29.2% of the 1466 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AXTA was trading at $33.75 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.2B. The 52-week trading range was $24.94 to $38.61. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AXTA - Latest Insights

AXTA
Oct 16, 2026, 9:51 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $34.12
Real-time Price: $33.75 info
Change: -$0.370 (-1%) info
Market Cap: $7.223B info
AXTA
Oct 15, 2026, 10:11 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $33.73
Real-time Price: $33.75 info
Change: +$0.025 (+0.07%) info
Market Cap: $7.223B info
AXTA
Oct 08, 2026, 9:26 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $32.42
Real-time Price: $33.75 info
Change: +$1.34 (+4%) info
Market Cap: $7.223B info
AXTA
Oct 05, 2026, 12:42 PM EDT
Filing Type: 425
Importance Score:
8
Price at Filing: $33.03
Real-time Price: $33.75 info
Change: +$0.720 (+2%) info
Market Cap: $7.223B info
AXTA
Sep 17, 2026, 2:25 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $33.16
Real-time Price: $33.75 info
Change: +$0.590 (+2%) info
Market Cap: $7.223B info